{"groups":[{"description":"Participants who consented to participate.","id":"FG000","title":"All Participants"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"51"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"27"}],"type":"Enrolled and Registered"},{"achievements":[{"groupId":"FG000","numSubjects":"19"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"32"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"A total of fifty-one participants consented and were eligible for the study, but twenty-seven of them started the study interventions.","recruitmentDetails":"Participants were recruited from 03/21/2022 through 06/29/2023 at one cancer center, in North Carolina. Subjects were enrolled in the study between 03/31/2022 through 06/29/2023."}